Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Apr;76(1):24–29.

T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).

A J Barnett 1, B D Tait 1, M A Barnett 1, B H Toh 1
PMCID: PMC1541735  PMID: 2525437

Abstract

Studies of T lymphocyte subsets were carried out in a group of 50 scleroderma patients, of whom 46 were also HLA phenotyped. The total lymphocyte count was depressed in 22 patients, and CD4 (helper cells) numbers were normal. CD8 (suppressor-cytotoxic) cells were reduced in 27 patients, and the CD4/CD8 number ratio increased above normal in three additional patients, resulting in 30 patients being classified as CD8-deficient. In the 46 patients HLA phenotyped, DRw8 was significantly increased in the entire patient group, but when the patients were subdivided into CD8-deficient (n = 29) and CD8-normal (n = 17), the increase in DRw8 was confined to the CD8-deficient patients. B18 was also increased in patients with limited sclerosis, while DR4 and DRw53 were significantly decreased and DR5 significantly increased in patients with more extensive skin sclerosis. These findings suggest that scleroderma is a heterogeneous condition and that this heterogeneity is reflected in different HLA profiles in patients subtyped according to their clinical profile and subpopulations of T cells.

Full text

PDF
24

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Palacios R., Ibáez de Kasep G. Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis. J Clin Lab Immunol. 1981 May;5(3):143–148. [PubMed] [Google Scholar]
  2. Alarcón G. S., Phillips R. M., Wasner C. K., Acton R. T., Barger B. O. DR antigens in systemic sclerosis: lack of clinical correlations. Tissue Antigens. 1985 Aug;26(2):156–158. doi: 10.1111/j.1399-0039.1985.tb00950.x. [DOI] [PubMed] [Google Scholar]
  3. Alderuccio F., Barnett A. J., Campbell J. H., Pedersen J. S., Toh B. H. Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis. Clin Exp Immunol. 1986 Apr;64(1):94–100. [PMC free article] [PubMed] [Google Scholar]
  4. Alderuccio F., Toh B. H., Barnett A. J., Pedersen J. S. Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis. J Immunol. 1986 Sep 15;137(6):1855–1859. [PubMed] [Google Scholar]
  5. Baron M., Keystone E. C., Gladman D. D., Lee P., Poplonski L. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma. Clin Exp Immunol. 1981 Oct;46(1):70–76. [PMC free article] [PubMed] [Google Scholar]
  6. Birnbaum N. S., Rodnan G. P., Rabin B. S., Bassion S. Histocompatibility antigens in progressive systemic sclerosis (scleroderma). J Rheumatol. 1977 Winter;4(4):425–428. [PubMed] [Google Scholar]
  7. Böyum A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest Suppl. 1968;97:31–50. [PubMed] [Google Scholar]
  8. Claudy A. L., Le Petit J. C., Barthelemy H., Garcier F. T-cell imbalance in progressive systemic sclerosis defined by monoclonal antibodies. Arch Dermatol Res. 1982;274(1-2):189–192. doi: 10.1007/BF00510373. [DOI] [PubMed] [Google Scholar]
  9. Crouzet J., Marbach M. C., Camus J. P., Godeau P., Herreman G., Richier D., Hors J., Dausset J. Recherche d'une association entre antigènes HL-A et sclérodermie systémique. Nouv Presse Med. 1975 Oct 18;4(35):2489–2492. [PubMed] [Google Scholar]
  10. Gladman D. D., Keystone E. C., Baron M., Lee P., Cane D., Mervert H. Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum. 1981 Jun;24(6):854–856. doi: 10.1002/art.1780240614. [DOI] [PubMed] [Google Scholar]
  11. Gupta S., Malaviya A. N., Rajagopalan P., Good R. A. Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis. Clin Exp Immunol. 1979 Nov;38(2):342–347. [PMC free article] [PubMed] [Google Scholar]
  12. Hughes P., Gelsthorpe K., Doughty R. W., Rowell N. R., Rosenthal F. D., Sneddon I. B. The association of HLA-B8 with visceral disease in systemic sclerosis. Clin Exp Immunol. 1978 Mar;31(3):351–356. [PMC free article] [PubMed] [Google Scholar]
  13. Inoshita T., Whiteside T. L., Rodnan G. P., Taylor F. H. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma). J Lab Clin Med. 1981 Feb;97(2):264–277. [PubMed] [Google Scholar]
  14. Kallenberg C. G., Van der Voort-Beelen J. M., D'Amaro J., The T. H. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol. 1981 Mar;43(3):478–485. [PMC free article] [PubMed] [Google Scholar]
  15. Keystone E. C., Lau C., Gladman D. D., Wilkinson S., Lee P., Shore A. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol. 1982 May;48(2):443–448. [PMC free article] [PubMed] [Google Scholar]
  16. Livingston J. Z., Scott T. E., Wigley F. M., Anhalt G. J., Bias W. B., McLean R. H., Hochberg M. C. Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets. J Rheumatol. 1987 Jun;14(3):512–518. [PubMed] [Google Scholar]
  17. Loken M. R., Herzenber L. A. Analysis of cell populations with a fluorescence-activated cell sorter. Ann N Y Acad Sci. 1975 Jun 30;254:163–171. doi: 10.1111/j.1749-6632.1975.tb29166.x. [DOI] [PubMed] [Google Scholar]
  18. Lynch C. J., Singh G., Whiteside T. L., Rodnan G. P., Medsger T. A., Jr, Rabin B. S. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol. 1982 Oct;2(4):314–318. doi: 10.1007/BF00915073. [DOI] [PubMed] [Google Scholar]
  19. Niks M., Rovenský J., Nyulassy S., Buc M., Stefanovic J., Zitnan D. Lack of association of HLA-DR antigens with progressive systemic sclerosis (scleroderma). Tissue Antigens. 1982 Mar;19(3):238–239. doi: 10.1111/j.1399-0039.1982.tb01446.x. [DOI] [PubMed] [Google Scholar]
  20. Roumm A. D., Whiteside T. L., Medsger T. A., Jr, Rodnan G. P. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum. 1984 Jun;27(6):645–653. doi: 10.1002/art.1780270607. [DOI] [PubMed] [Google Scholar]
  21. Steen V. D., Ziegler G. L., Rodnan G. P., Medsger T. A., Jr Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984 Feb;27(2):125–131. doi: 10.1002/art.1780270202. [DOI] [PubMed] [Google Scholar]
  22. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  23. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  24. Todd J. A., Acha-Orbea H., Bell J. I., Chao N., Fronek Z., Jacob C. O., McDermott M., Sinha A. A., Timmerman L., Steinman L. A molecular basis for MHC class II--associated autoimmunity. Science. 1988 May 20;240(4855):1003–1009. doi: 10.1126/science.3368786. [DOI] [PubMed] [Google Scholar]
  25. Werner C., Klouda P. T., Corréa M. C., Vassalli P., Jeannet M. Isolation of B and T lymphocytes by nylon fiber columns. Tissue Antigens. 1977 Apr;9(4):227–229. doi: 10.1111/j.1399-0039.1977.tb01112.x. [DOI] [PubMed] [Google Scholar]
  26. Whiteside T. L., Kumagai Y., Roumm A. D., Almendinger R., Rodnan G. P. Suppressor cell function and T lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis. Arthritis Rheum. 1983 Jul;26(7):841–847. doi: 10.1002/art.1780260704. [DOI] [PubMed] [Google Scholar]
  27. Whiteside T. L., Medsger T. A., Jr, Rodnan G. P. HLA-DR antigens in progressive systemic sclerosis (scleroderma). J Rheumatol. 1983 Feb;10(1):128–131. [PubMed] [Google Scholar]
  28. Winkelstein A., Bernstein M. L., Stevens M. A., Rodnan G. P., Medsger T. A., Jr, Dobson S. A. Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis. J Lab Clin Med. 1982 Aug;100(2):240–247. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES